A research team has developed a biodegradable polymer-based delivery system that efficiently transports mRNA.
A research team led by Professor Won Jong Kim from the Department of Chemistry at POSTECH, in collaboration with the Korea ...
A research team from POSTECH has developed a biodegradable polymer-based delivery system that efficiently transports mRNA.
The LNP-mRNA modality is a novel approach that uses lipid nanoparticles to deliver messenger RNA into cells. The mRNA acts as ...
Scientists have progressed from merely provoking an anti-cancer immune response to designing it ...
The mRNA vaccine against avian influenza presents several advantages and disadvantages: Advantages: Rapid Development and Production; Non-Infectious Nature; Strong Immune Response; Adaptability to ...
Researchers have found a new way to reduce the effects of pre-eclampsia using mRNA-lipid nanoparticle therapies.
Ethris Presents Positive Topline Phase 1 Data with mRNA Lead Candidate ETH47 for Uncontrolled Asthma
Ethris GmbH, a leading biotechnology company pioneering next-generation RNA therapeutics and vaccines, today announced promising topline data from the completed Phase 1 clinical trial of its lead mRNA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback